Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide plus gluten-free diet in newly diagnosed coeliac disease
ACTRN12609000738224Phase 2Completed
- Sponsor
- Monash University Eastern Clinical Research Unit
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in celiac disease comparing Budesonide + gluten-free diet with Placebo + gluten-free diet (2 arms). Primary endpoint: Proportion of patients achieving mucosal healing (Marsh I or better). Started Apr 2010; status: completed.
02
Drugs
budesonide
03
Conditions
celiac disease
Beyond the preview
Go deeper on ACTRN12609000738224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000738224.